Literature DB >> 26846455

Demyelinating disease: NMO spectrum disorders: clinical or molecular classification?

Sean J Pittock1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26846455     DOI： 10.1038/nrneurol.2016.9

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.

Authors:  P J Waters; A McKeon; M I Leite; S Rajasekharan; V A Lennon; A Villalobos; J Palace; J N Mandrekar; A Vincent; A Bar-Or; S J Pittock
Journal:  Neurology       Date:  2012-02-01       Impact factor: 9.910

2.  Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.

Authors:  Kensuke Ikeda; Naoki Kiyota; Hiroshi Kuroda; Douglas Kazutoshi Sato; Shuhei Nishiyama; Toshiyuki Takahashi; Tatsuro Misu; Ichiro Nakashima; Kazuo Fujihara; Masashi Aoki
Journal:  Mult Scler       Date:  2014-09-25       Impact factor: 6.312

3.  Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.

Authors:  Douglas Kazutoshi Sato; Dagoberto Callegaro; Marco Aurelio Lana-Peixoto; Patrick J Waters; Frederico M de Haidar Jorge; Toshiyuki Takahashi; Ichiro Nakashima; Samira Luisa Apostolos-Pereira; Natalia Talim; Renata Faria Simm; Angelina Maria Martins Lino; Tatsuro Misu; Maria Isabel Leite; Masashi Aoki; Kazuo Fujihara
Journal:  Neurology       Date:  2014-01-10       Impact factor: 9.910

Review 4.  Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.

Authors:  Sean J Pittock; Claudia F Lucchinetti
Journal:  Ann N Y Acad Sci       Date:  2015-06-10       Impact factor: 5.691

Review 5.  The spectrum of neuromyelitis optica.

Authors:  Dean M Wingerchuk; Vanda A Lennon; Claudia F Lucchinetti; Sean J Pittock; Brian G Weinshenker
Journal:  Lancet Neurol       Date:  2007-09       Impact factor: 44.182

Review 6.  The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.

Authors:  Claudia F Lucchinetti; Yong Guo; Bogdan F Gh Popescu; Kazuo Fujihara; Yasuto Itoyama; Tatsuro Misu
Journal:  Brain Pathol       Date:  2014-01       Impact factor: 6.508

7.  Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria.

Authors:  Akiyuki Uzawa; Masahiro Mori; Tomohiko Uchida; Hiroki Masuda; Ryohei Ohtani; Satoshi Kuwabara
Journal:  Mult Scler       Date:  2015-11-09       Impact factor: 6.312

8.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

Review 9.  Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?

Authors:  Scott S Zamvil; Anthony J Slavin
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-01-22

10.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910
  10 in total
  4 in total

Review 1.  The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Authors:  Ruth Geraldes; Olga Ciccarelli; Frederik Barkhof; Nicola De Stefano; Christian Enzinger; Massimo Filippi; Monika Hofer; Friedemann Paul; Paolo Preziosa; Alex Rovira; Gabriele C DeLuca; Ludwig Kappos; Tarek Yousry; Franz Fazekas; Jette Frederiksen; Claudio Gasperini; Jaume Sastre-Garriga; Nikos Evangelou; Jacqueline Palace
Journal:  Nat Rev Neurol       Date:  2018-03-09       Impact factor: 42.937

Review 2.  Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.

Authors:  Jeffrey L Bennett
Journal:  J Neuroophthalmol       Date:  2016-09       Impact factor: 3.042

3.  Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.

Authors:  A Sebastian López-Chiriboga; Masoud Majed; James Fryer; Divyanshu Dubey; Andrew McKeon; Eoin P Flanagan; Jiraporn Jitprapaikulsan; Naga Kothapalli; Jan-Mendelt Tillema; John Chen; Brian Weinshenker; Dean Wingerchuk; Jessica Sagen; Avi Gadoth; Vanda A Lennon; B Mark Keegan; Claudia Lucchinetti; Sean J Pittock
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

4.  Diagnosing MRI-negative autoimmune diseases.

Authors:  Carsten Finke
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-04-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.